Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$12.55 - $17.22 $668,915 - $917,825
-53,300 Reduced 48.5%
56,605 $956,000
Q4 2023

Feb 14, 2024

BUY
$9.64 - $14.59 $850,489 - $1.29 Million
88,225 Added 406.94%
109,905 $1.55 Million
Q3 2023

Nov 14, 2023

SELL
$10.3 - $15.99 $2.43 Million - $3.78 Million
-236,370 Reduced 91.6%
21,680 $223,000
Q2 2023

Aug 14, 2023

BUY
$8.48 - $16.48 $1.97 Million - $3.83 Million
232,151 Added 896.37%
258,050 $4.25 Million
Q1 2023

May 15, 2023

SELL
$6.41 - $9.95 $314,090 - $487,549
-49,000 Reduced 65.42%
25,899 $237,000
Q4 2022

Feb 14, 2023

BUY
$5.02 - $10.0 $375,992 - $748,990
74,899 New
74,899 $536,000
Q2 2022

Aug 16, 2022

BUY
$1.07 - $6.95 $5,153 - $33,471
4,816 Added 16.96%
33,220 $81,000
Q1 2022

May 17, 2022

SELL
$5.46 - $8.29 $285,366 - $433,276
-52,265 Reduced 64.79%
28,404 $194,000
Q4 2021

Feb 15, 2022

BUY
$7.34 - $11.18 $464,416 - $707,380
63,272 Added 363.69%
80,669 $652,000
Q2 2021

Aug 16, 2021

SELL
$6.73 - $9.05 $415,967 - $559,362
-61,808 Reduced 78.04%
17,397 $117,000
Q1 2021

May 18, 2021

BUY
$6.61 - $10.07 $407,572 - $620,916
61,660 Added 351.44%
79,205 $716,000
Q4 2020

Feb 17, 2021

BUY
$5.03 - $7.95 $88,251 - $139,482
17,545 New
17,545 $117,000
Q4 2019

Feb 14, 2020

SELL
$3.34 - $7.7 $46,155 - $106,406
-13,819 Closed
0 $0
Q3 2019

Nov 14, 2019

BUY
$1.92 - $4.47 $26,532 - $61,770
13,819 New
13,819 $57,000

Others Institutions Holding AVDL

About AVADEL PHARMACEUTICALS PLC


  • Ticker AVDL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 60,581,300
  • Market Cap $650M
  • Description
  • Avadel Pharmaceuticals plc operates as a biopharmaceutical company in the United States. Its lead product candidate is FT218, a formulation of sodium oxybate, which is in a Phase 3 clinical trial for the treatment of excessive daytime sleepiness and cataplexy in adults with narcolepsy. The company was formerly known as Flamel Technologies SA and...
More about AVDL
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.